{
    "clinical_study": {
        "@rank": "89256", 
        "brief_summary": {
            "textblock": "This study allows patients who need a new anti-HIV treatment to take tenofovir disoproxil\n      fumarate (tenofovir DF), an experimental drug. This study also looks at any side effects the\n      drug causes."
        }, 
        "brief_title": "A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "HIV-1-infected patients who are currently receiving stable antiretroviral therapy add\n      tenofovir DF to their regimen. Study participation lasts for approximately 48 weeks.\n      Interested patients should contact their physicians."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        You may be eligible for this study if you:\n\n          -  Are HIV-positive.\n\n          -  Have a viral load greater than or equal to 10,000 copies/ml.\n\n          -  Have a CD4 count less than or equal to 50 cells/mm3, or have a CD4 count greater than\n             50 and no more than 200 cells/mm3 with an opportunistic (AIDS-related) infection\n             within 90 days of study entry. (Patients with a CD4 count above 200 cells/mm3 may be\n             considered depending on drug supply.)\n\n          -  Are at least 18 years old.\n\n          -  Agree to use barrier methods of birth control (such as condoms) while on the study\n             and for 30 days afterward.\n\n          -  Have a life expectancy of at least one year.\n\n        Exclusion Criteria\n\n        You will not be eligible for this study if you:\n\n          -  Have a history of a serious kidney or bone disease.\n\n          -  Have severe nausea, vomiting, or trouble taking medications by mouth.\n\n          -  Are pregnant or breast-feeding.\n\n          -  Abuse alcohol or other substances that your doctor thinks would interfere with taking\n             this medicine.\n\n          -  Are taking any medicines that interfere with kidney functions."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "300", 
        "firstreceived_date": "January 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002453", 
            "org_study_id": "283C", 
            "secondary_id": "GS-99-908"
        }, 
        "intervention": {
            "intervention_name": "Tenofovir disoproxil fumarate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Tenofovir", 
                "Tenofovir disoproxil", 
                "Anti-Retroviral Agents"
            ]
        }, 
        "keyword": [
            "HIV-1", 
            "Drug Therapy, Combination", 
            "Disease Progression", 
            "Anti-HIV Agents"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Foster City", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94404"
                }, 
                "name": "Tenofovir Coordinating Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "An Open-Label, Multicenter, Compassionate Access Study of the Safety of Tenofovir Disoproxil Fumarate Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Patients", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002453"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gilead Sciences", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 1999", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2000"
    }, 
    "geocoordinates": {
        "Tenofovir Coordinating Center": "37.559 -122.271"
    }
}